Literature DB >> 21359590

Engineered cartilage maturation regulates cytokine production and interleukin-1β response.

Silvia Francioli1, Carola Cavallo, Brunella Grigolo, Ivan Martin, Andrea Barbero.   

Abstract

BACKGROUND: Because the injured joint has an actively inflammatory environment, the survival and repair potential of cartilage grafts may be influenced by inflammatory processes. Understanding the interactions of those processes with the graft may lead to concepts for pharmacologic or surgical solutions allowing improved cartilage repair. QUESTIONS/PURPOSES: We asked whether the maturation level of cartilaginous tissues generated in vitro by expanded human articular chondrocytes (HACs) modulate (1) the spontaneous production of cytokines and (2) the response to interleukin (IL)-1β.
METHODS: Twelve pellets/donor prepared with monolayer-expanded HACs (n = 6 donors) were evaluated at six different culture times for mRNA expression (n = 72) and spontaneous baseline release of monocyte chemoattractant protein (MCP)-1, IL-8, and transforming growth factor (TGF)-β1 (n = 72). We cultured 24 pellets/donor from each of four donors for 1 or 14 days (defined as immature and mature, respectively) and exposed the pellets to IL-1β for 3 days. MCP-1, IL-8, TGF-β1, and metalloprotease (MMP)-1 and MMP-13 were quantified in pellets and culture supernatants.
RESULTS: By increasing culture time, the spontaneous release of IL-8 and MCP-1 decreased (12.0- and 5.5-fold, respectively), whereas that of TGF-β1 increased (5.4-fold). As compared with immature pellets, mature pellets responded to IL-1β by releasing lower amounts of MMP-1 (2.9-fold) and MMP-13 (1.7-fold) and increased levels of IL-8, MCP-1, and TGF-β1 (1.5-, 5.0-, and 7.5-fold, respectively). IL-8 and MCP-1 promptly returned to baseline on withdrawal of IL-1β.
CONCLUSIONS: Our observations suggest more mature cartilaginous tissues are more resistant to IL-1β exposure and can activate chemokines required to initiate tissue repair processes. CLINICAL RELEVANCE: The implantation of more mature cartilaginous tissues might provide superior graft survival and improve/accelerate cartilage repair.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21359590      PMCID: PMC3171533          DOI: 10.1007/s11999-011-1826-x

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  49 in total

1.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

2.  The role of C-C chemokines and their receptors in osteoarthritis.

Authors:  G H Yuan; K Masuko-Hongo; M Sakata; J Tsuruha; H Onuma; H Nakamura; H Aoki; T Kato; K Nishioka
Journal:  Arthritis Rheum       Date:  2001-05

3.  Cytoskeletal architecture and cathepsin B trafficking in human articular chondrocytes.

Authors:  R Zwicky; A Baici
Journal:  Histochem Cell Biol       Date:  2000-11       Impact factor: 4.304

4.  Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis.

Authors:  David G Stokes; Gang Liu; Ibsen B Coimbra; Sonsoles Piera-Velazquez; Robert M Crowl; Sergio A Jiménez
Journal:  Arthritis Rheum       Date:  2002-02

Review 5.  Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation.

Authors:  E Hedbom; H J Häuselmann
Journal:  Cell Mol Life Sci       Date:  2002-01       Impact factor: 9.261

6.  Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro.

Authors:  M Jakob; O Démarteau; D Schäfer; B Hintermann; W Dick; M Heberer; I Martin
Journal:  J Cell Biochem       Date:  2001-03-26       Impact factor: 4.429

7.  Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.

Authors:  L C Tetlow; D J Adlam; D E Woolley
Journal:  Arthritis Rheum       Date:  2001-03

8.  Interleukin-1beta induces different gene expression of stromelysin, aggrecan and tumor-necrosis-factor-stimulated gene 6 in human osteoarthritic chondrocytes in vitro.

Authors:  J Stöve; K Huch; K P Günther; H P Scharf
Journal:  Pathobiology       Date:  2000 May-Jun       Impact factor: 4.342

Review 9.  Cytokines in cartilage injury and repair.

Authors:  M Lotz
Journal:  Clin Orthop Relat Res       Date:  2001-10       Impact factor: 4.176

10.  Anabolic and catabolic responses of human articular chondrocytes to varying oxygen percentages.

Authors:  Simon Ströbel; Marko Loparic; David Wendt; Andreas D Schenk; Christian Candrian; Raija L P Lindberg; Florina Moldovan; Andrea Barbero; Ivan Martin
Journal:  Arthritis Res Ther       Date:  2010-03-02       Impact factor: 5.156

View more
  12 in total

1.  Beneficial effects of cerium oxide nanoparticles in development of chondrocyte-seeded hydrogel constructs and cellular response to interleukin insults.

Authors:  Sathish Ponnurangam; Grace D O'Connell; Irina V Chernyshova; Katherine Wood; Clark Tung-Hui Hung; Ponisseril Somasundaran
Journal:  Tissue Eng Part A       Date:  2014-06-25       Impact factor: 3.845

2.  Chondrocyte and mesenchymal stem cell derived engineered cartilage exhibits differential sensitivity to pro-inflammatory cytokines.

Authors:  Bhavana Mohanraj; Alice H Huang; Meira J Yeger-McKeever; Megan J Schmidt; George R Dodge; Robert L Mauck
Journal:  J Orthop Res       Date:  2018-07-13       Impact factor: 3.494

3.  sb203580 preconditioning recharges matrix-expanded human adult stem cells for chondrogenesis in an inflammatory environment - A feasible approach for autologous stem cell based osteoarthritic cartilage repair.

Authors:  Ying Zhang; Tyler Pizzute; Jingting Li; Fan He; Ming Pei
Journal:  Biomaterials       Date:  2015-06-20       Impact factor: 12.479

4.  Antioxidation of decellularized stem cell matrix promotes human synovium-derived stem cell-based chondrogenesis.

Authors:  Ming Pei; Ying Zhang; Jingting Li; Dongquan Chen
Journal:  Stem Cells Dev       Date:  2012-12-16       Impact factor: 3.272

5.  Dexamethasone Release from Within Engineered Cartilage as a Chondroprotective Strategy Against Interleukin-1α.

Authors:  Brendan L Roach; Arta Kelmendi-Doko; Elaine C Balutis; Kacey G Marra; Gerard A Ateshian; Clark T Hung
Journal:  Tissue Eng Part A       Date:  2016-03-31       Impact factor: 3.845

6.  Scaffold-based delivery of a clinically relevant anti-angiogenic drug promotes the formation of in vivo stable cartilage.

Authors:  Matteo Centola; Franca Abbruzzese; Celeste Scotti; Andrea Barbero; Gianluca Vadalà; Vincenzo Denaro; Ivan Martin; Marcella Trombetta; Alberto Rainer; Anna Marsano
Journal:  Tissue Eng Part A       Date:  2013-05-30       Impact factor: 3.845

7.  Muscle cell-derived factors inhibit inflammatory stimuli-induced damage in hMSC-derived chondrocytes.

Authors:  R S Rainbow; H Kwon; A T Foote; R C Preda; D L Kaplan; L Zeng
Journal:  Osteoarthritis Cartilage       Date:  2013-04-20       Impact factor: 6.576

8.  Vascular Endothelial Growth Factor Sequestration Enhances In Vivo Cartilage Formation.

Authors:  Carolina M Medeiros Da Cunha; Valeria Perugini; Petra Bernegger; Matteo Centola; Andrea Barbero; Anna L Guildford; Matteo Santin; Andrea Banfi; Ivan Martin; Anna Marsano
Journal:  Int J Mol Sci       Date:  2017-11-21       Impact factor: 5.923

9.  Clinical Trial and In Vitro Study for the Role of Cartilage and Synovia in Acute Articular Infection.

Authors:  Elia R Langenmair; Eva J Kubosch; Gian M Salzmann; Samuel Beck; Hagen Schmal
Journal:  Mediators Inflamm       Date:  2015-11-10       Impact factor: 4.711

10.  Notochordal cell conditioned medium (NCCM) regenerates end-stage human osteoarthritic articular chondrocytes and promotes a healthy phenotype.

Authors:  Sebastian Müller; Lina Acevedo; Xiaomei Wang; M Zia Karim; Ajay Matta; Arne Mehrkens; Stefan Schaeren; Sandra Feliciano; Marcel Jakob; Ivan Martin; Andrea Barbero; W Mark Erwin
Journal:  Arthritis Res Ther       Date:  2016-06-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.